DARPin REAGENTS THAT DISTINGUISH ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE SAMPLES
AssigneeArizona Board of Regents on behalf of Arizona State University
InventorsMichael Sierks, Stephanie Williams
Life of this patent
Estimating the term…
Abstract
Disclosed are diagnostics kits and compositions for neurodegenerative diseases, and in particular to design ankyrin repeat protein (DARPins) reagents that distinguish Alzheimer's disease (AD) from Parkinson's disease (PD). Methods of diagnosing, monitoring treatment efficacy and developing treatments for neurodegenerative diseases, such as AD and PD are disclosed based upon the use of the AD or PD specific DARPins.
Claims20
A kit for detecting a neurodegenerative disease or monitoring the efficacy of a neurodegenerative treatment, comprising at least one molecule capable of detecting at least one neurodegenerative-associated design ankyrin repeat protein (DARPin) and directions for using the kit.
A kit for detecting a neurodegenerative disease or monitoring the efficacy of a neurodegenerative treatment, the kit comprising at least one neurodegenerative-associated design ankyrin repeat protein (DARPin).
A composition comprising at least one neurodegenerative-associated design ankyrin repeat protein (DARPin) specific for detecting Alzheimer's Disease (AD) and/or Parkinson's Disease (PD).
Dependencies are inferred from the claim text.